Braskem SA ADR (BAK)

Cost of Revenue

R$64.30B

TTM · Period ending: · BRL

BAK logo

BAK Cost of Revenue

Latest reportedR$64.30B BRL
BAK TTM Cost of Revenue · BRL (R$1.19B → R$64.30B)
High-resolution chart · PNG

BAK cost of revenue history

Trailing twelve months (TTM) · BRL. Each value covers four complete reported quarters.

Braskem SA ADR Cost of Revenue — Trailing twelve months (TTM) (BRL)
Period endingCost of Revenue (BRL)
64,304,000,000
65,399,000,000
69,161,000,000
70,513,000,000
72,665,000,000
72,855,000,000
71,414,000,000
69,092,000,000
66,183,000,000
65,796,000,000
67,548,000,000
70,933,000,000
77,985,000,000
82,020,000,000
85,160,429,000
87,602,692,000
84,439,562,000
79,715,462,000
73,568,033,000
65,855,770,000
58,287,900,000
51,335,000,000
47,332,000,000
44,798,362,000
44,022,514,000
46,041,514,000
45,806,857,000
47,405,495,000
48,468,624,000
47,297,161,000
46,407,950,000
42,705,079,000
39,117,087,000
37,592,907,000
36,177,408,000
35,943,279,000
35,746,347,000
35,399,089,000
35,412,061,000
36,010,061,000
37,041,086,000
37,236,594,000
36,902,478,000
37,460,478,000
37,551,131,000
38,323,319,000
40,057,456,000
40,003,456,000
38,958,517,000
37,829,343,000
35,820,392,000
34,101,392,000
33,592,848,000
33,400,234,000
32,684,127,000
32,390,901,000
31,658,318,000
30,517,532,000
29,308,177,000
27,529,504,000
25,909,589,000
24,129,122,000
21,411,775,000
18,854,474,000
15,785,420,000
13,475,666,000
12,572,203,000
12,085,163,000
13,332,391,000
14,050,307,820
15,034,185,825
15,880,718,425
15,327,379,380
14,145,288,037
13,002,746,697
11,250,023,193
10,582,526,169
10,545,186,502
10,227,718,327
10,642,032,222
10,181,693,633
10,114,680,869
10,325,953,018
10,397,517,770
10,357,691,328
10,206,065,819
9,237,498,504
8,636,531,486
8,015,486,654
7,396,681,677
7,821,585,849
10,533,352,175
9,354,867,979
8,110,544,801
6,636,712,953
2,571,293,814
2,204,665,006
2,355,272,316
2,527,970,130
2,447,925,608
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.